10 20 30 40 50 60 70 80 1YUY - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER VIRAL PROTEIN 14-FEB-05 1YUY
TITLE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE TITLE 2 GENOTYPE 2A
COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA-DEPENDENT RNA POLYMERASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: GENOTYPE 2A
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_TAXID: 11103; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET-21B
KEYWDS NS5B POLYMERASE GENOTYPE 2A, VIRAL PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR B.K.BISWAL,M.M.CHERNEY,M.WANG,L.CHAN,C.G.YANNOPOULOS, AUTHOR 2 D.BILIMORIA,O.NICOLAS,J.BEDARD,M.N.G.JAMES
REVDAT 3 24-FEB-09 1YUY 1 VERSN REVDAT 2 10-MAY-05 1YUY 1 JRNL REVDAT 1 22-MAR-05 1YUY 0
JRNL AUTH B.K.BISWAL,M.M.CHERNEY,M.WANG,L.CHAN, JRNL AUTH 2 C.G.YANNOPOULOS,D.BILIMORIA,O.NICOLAS,J.BEDARD, JRNL AUTH 3 M.N.G.JAMES JRNL TITL CRYSTAL STRUCTURES OF THE RNA DEPENDENT RNA JRNL TITL 2 POLYMERASE GENOTYPE 2A OF HEPATITIS C VIRUS REVEAL JRNL TITL 3 TWO CONFORMATIONS AND SUGGEST MECHANISMS OF JRNL TITL 4 INHIBITION BY NON-NUCLEOSIDE INHIBITORS. JRNL REF J.BIOL.CHEM. V. 280 18202 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15746101 JRNL DOI 10.1074/JBC.M413410200
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2915925.700 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 65644 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3329 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 9459 REMARK 3 BIN R VALUE (WORKING SET) : 0.2970 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 508 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4355 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 434 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.24000 REMARK 3 B22 (A**2) : -6.44000 REMARK 3 B33 (A**2) : 7.68000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.22 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.26 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.80 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 51.01 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1YUY COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-FEB-05. REMARK 100 THE RCSB ID CODE IS RCSB031947.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.100028 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : BLU-ICE REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65644 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 8000, 0.2M AMMONIUM REMARK 280 SULPHATE, 80MM SODIUM CITRATE PH 6.0, 7% GLYCEROL, 4% 1,6 REMARK 280 HEXANEDIOL AND 1% BENZAMIDINE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.59600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.59600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 32.19800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 107.20850 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 32.19800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 107.20850 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 61.59600 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 32.19800 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 107.20850 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 61.59600 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 32.19800 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 107.20850 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 149 REMARK 465 THR A 150 REMARK 465 LYS A 151 REMARK 465 GLY A 152 REMARK 465 GLY A 153 REMARK 465 VAL A 564 REMARK 465 SER A 565 REMARK 465 ARG A 566 REMARK 465 ALA A 567 REMARK 465 ARG A 568 REMARK 465 PRO A 569 REMARK 465 ARG A 570
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 15 153.01 173.86 REMARK 500 LEU A 260 -56.23 -131.10 REMARK 500 SER A 347 61.54 73.21 REMARK 500 ALA A 348 57.30 -160.20 REMARK 500 VAL A 424 -66.86 -98.67 REMARK 500 THR A 476 64.57 60.13 REMARK 500 LYS A 535 -74.21 -50.03 REMARK 500 LEU A 536 94.13 76.41 REMARK 500 SER A 548 -42.97 170.66 REMARK 500 ASP A 559 51.86 70.32 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 571 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 572 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 573 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 574
REMARK 999 REMARK 999 SEQUENCE AUTHOR STATES THAT A PCR FUSION APPROACH WAS USED, AS REMARK 999 IT IS WIDELY USED TO CONSTRUCT GENES WHEN NO ACTUAL TEMPLATE IS REMARK 999 AVAILABLE (EG BLIGHT JK ET AL. SCIENCE. 2000 DEC 8;290(5498): REMARK 999 1972-4) TO BUILT A CONSENSUS CDNA OF THE HCV POLYMERASE GENOTYPE REMARK 999 2A. THE CONSENSUS SEQUENCE WAS BASED ON THE ALIGNMENT OF AT REMARK 999 LEAST TEN COMPLETE SEQUENCES AVAILABLE IN THE NCBI DATABANK. THE REMARK 999 GENE WAS PRODUCED COULD BE CONSIDERED SYNTHETIC AS IT WAS BASED REMARK 999 ON THESE APPROXIMATELY 10 POLYMERASE SEQUENCES (AND WILL REMARK 999 THEREFORE NOT CORRESPOND TO ANY SPECIFIC POLYMERASE SEQUENCE REMARK 999 FOUND IN NATURE) AND THE CODON USAGE WAS ALSO MODIFIED TO REMARK 999 MAXIMIZE THE EXPRESSION IN BACTERIA.
DBREF 1YUY A 1 570 UNP P26660 POLG_HCVJ6 2443 3012
SEQADV 1YUY PRO A 25 UNP P26660 SER 2467 SEE REMARK 999 SEQADV 1YUY THR A 150 UNP P26660 ALA 2592 SEE REMARK 999 SEQADV 1YUY ALA A 156 UNP P26660 PRO 2598 SEE REMARK 999 SEQADV 1YUY LYS A 212 UNP P26660 ARG 2654 SEE REMARK 999 SEQADV 1YUY VAL A 309 UNP P26660 ILE 2751 SEE REMARK 999 SEQADV 1YUY PRO A 391 UNP P26660 SER 2833 SEE REMARK 999
SEQRES 1 A 570 SER MET SER TYR SER TRP THR GLY ALA LEU ILE THR PRO SEQRES 2 A 570 CYS SER PRO GLU GLU GLU LYS LEU PRO ILE ASN PRO LEU SEQRES 3 A 570 SER ASN SER LEU LEU ARG TYR HIS ASN LYS VAL TYR CYS SEQRES 4 A 570 THR THR SER LYS SER ALA SER LEU ARG ALA LYS LYS VAL SEQRES 5 A 570 THR PHE ASP ARG MET GLN VAL LEU ASP ALA TYR TYR ASP SEQRES 6 A 570 SER VAL LEU LYS ASP ILE LYS LEU ALA ALA SER LYS VAL SEQRES 7 A 570 SER ALA ARG LEU LEU THR LEU GLU GLU ALA CYS GLN LEU SEQRES 8 A 570 THR PRO PRO HIS SER ALA ARG SER LYS TYR GLY PHE GLY SEQRES 9 A 570 ALA LYS GLU VAL ARG SER LEU SER GLY ARG ALA VAL ASN SEQRES 10 A 570 HIS ILE LYS SER VAL TRP LYS ASP LEU LEU GLU ASP SER SEQRES 11 A 570 GLN THR PRO ILE PRO THR THR ILE MET ALA LYS ASN GLU SEQRES 12 A 570 VAL PHE CYS VAL ASP PRO THR LYS GLY GLY LYS LYS ALA SEQRES 13 A 570 ALA ARG LEU ILE VAL TYR PRO ASP LEU GLY VAL ARG VAL SEQRES 14 A 570 CYS GLU LYS MET ALA LEU TYR ASP VAL THR GLN LYS LEU SEQRES 15 A 570 PRO GLN ALA VAL MET GLY ALA SER TYR GLY PHE GLN TYR SEQRES 16 A 570 SER PRO ALA GLN ARG VAL GLU PHE LEU LEU LYS ALA TRP SEQRES 17 A 570 ALA GLU LYS LYS ASP PRO MET GLY PHE SER TYR ASP THR SEQRES 18 A 570 ARG CYS PHE ASP SER THR VAL THR GLU ARG ASP ILE ARG SEQRES 19 A 570 THR GLU GLU SER ILE TYR GLN ALA CYS SER LEU PRO GLU SEQRES 20 A 570 GLU ALA ARG THR ALA ILE HIS SER LEU THR GLU ARG LEU SEQRES 21 A 570 TYR VAL GLY GLY PRO MET PHE ASN SER LYS GLY GLN SER SEQRES 22 A 570 CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU THR SEQRES 23 A 570 THR SER MET GLY ASN THR ILE THR CYS TYR VAL LYS ALA SEQRES 24 A 570 LEU ALA ALA CYS LYS ALA ALA GLY ILE VAL ALA PRO THR SEQRES 25 A 570 MET LEU VAL CYS GLY ASP ASP LEU VAL VAL ILE SER GLU SEQRES 26 A 570 SER GLN GLY THR GLU GLU ASP GLU ARG ASN LEU ARG ALA SEQRES 27 A 570 PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO GLY SEQRES 28 A 570 ASP PRO PRO ARG PRO GLU TYR ASP LEU GLU LEU ILE THR SEQRES 29 A 570 SER CYS SER SER ASN VAL SER VAL ALA LEU GLY PRO GLN SEQRES 30 A 570 GLY ARG ARG ARG TYR TYR LEU THR ARG ASP PRO THR THR SEQRES 31 A 570 PRO ILE ALA ARG ALA ALA TRP GLU THR VAL ARG HIS SER SEQRES 32 A 570 PRO VAL ASN SER TRP LEU GLY ASN ILE ILE GLN TYR ALA SEQRES 33 A 570 PRO THR ILE TRP VAL ARG MET VAL LEU MET THR HIS PHE SEQRES 34 A 570 PHE SER ILE LEU MET ALA GLN ASP THR LEU ASP GLN ASN SEQRES 35 A 570 LEU ASN PHE GLU MET TYR GLY SER VAL TYR SER VAL SER SEQRES 36 A 570 PRO LEU ASP LEU PRO ALA ILE ILE GLU ARG LEU HIS GLY SEQRES 37 A 570 LEU ASP ALA PHE SER LEU HIS THR TYR THR PRO HIS GLU SEQRES 38 A 570 LEU THR ARG VAL ALA SER ALA LEU ARG LYS LEU GLY ALA SEQRES 39 A 570 PRO PRO LEU ARG ALA TRP LYS SER ARG ALA ARG ALA VAL SEQRES 40 A 570 ARG ALA SER LEU ILE SER ARG GLY GLY ARG ALA ALA VAL SEQRES 41 A 570 CYS GLY ARG TYR LEU PHE ASN TRP ALA VAL LYS THR LYS SEQRES 42 A 570 LEU LYS LEU THR PRO LEU PRO GLU ALA ARG LEU LEU ASP SEQRES 43 A 570 LEU SER SER TRP PHE THR VAL GLY ALA GLY GLY GLY ASP SEQRES 44 A 570 ILE TYR HIS SER VAL SER ARG ALA ARG PRO ARG
HET SO4 A 571 5 HET SO4 A 572 5 HET SO4 A 573 5 HET SO4 A 574 5
HETNAM SO4 SULFATE ION
FORMUL 2 SO4 4(O4 S 2-) FORMUL 6 HOH *434(H2 O)
HELIX 1 1 ASN A 24 SER A 29 1 6 HELIX 2 2 TYR A 33 ASN A 35 5 3 HELIX 3 3 THR A 41 LYS A 43 5 3 HELIX 4 4 SER A 44 THR A 53 1 10 HELIX 5 5 ASP A 61 SER A 76 1 16 HELIX 6 6 THR A 84 LEU A 91 1 8 HELIX 7 7 GLY A 104 SER A 110 1 7 HELIX 8 8 SER A 112 ASP A 129 1 18 HELIX 9 9 ASP A 164 GLY A 188 1 25 HELIX 10 10 ALA A 189 TYR A 195 5 7 HELIX 11 11 SER A 196 GLU A 210 1 15 HELIX 12 12 CYS A 223 VAL A 228 1 6 HELIX 13 13 THR A 229 ALA A 242 1 14 HELIX 14 14 PRO A 246 LEU A 260 1 15 HELIX 15 15 THR A 286 GLY A 307 1 22 HELIX 16 16 GLY A 328 TYR A 346 1 19 HELIX 17 17 ASP A 359 ILE A 363 5 5 HELIX 18 18 PRO A 388 ARG A 401 1 14 HELIX 19 19 SER A 407 TYR A 415 1 9 HELIX 20 20 THR A 418 VAL A 424 1 7 HELIX 21 21 VAL A 424 ASP A 437 1 14 HELIX 22 22 SER A 455 LEU A 457 5 3 HELIX 23 23 ASP A 458 GLY A 468 1 11 HELIX 24 24 LEU A 469 SER A 473 5 5 HELIX 25 25 THR A 478 GLY A 493 1 16 HELIX 26 26 PRO A 496 GLY A 515 1 20 HELIX 27 27 GLY A 515 PHE A 526 1 12 HELIX 28 28 ASN A 527 VAL A 530 5 4 HELIX 29 29 LEU A 539 LEU A 544 1 6 HELIX 30 30 PHE A 551 ALA A 555 5 5
SHEET 1 A 5 TYR A 4 TRP A 6 0 SHEET 2 A 5 SER A 273 ARG A 277 -1 O TYR A 276 N SER A 5 SHEET 3 A 5 GLY A 264 PHE A 267 -1 N MET A 266 O GLY A 275 SHEET 4 A 5 THR A 136 ALA A 140 1 N ILE A 138 O PHE A 267 SHEET 5 A 5 LEU A 159 PRO A 163 -1 O TYR A 162 N THR A 137 SHEET 1 B 2 VAL A 37 CYS A 39 0 SHEET 2 B 2 VAL A 144 CYS A 146 -1 O PHE A 145 N TYR A 38 SHEET 1 C 3 PRO A 214 TYR A 219 0 SHEET 2 C 3 ASP A 319 GLU A 325 -1 O VAL A 322 N PHE A 217 SHEET 3 C 3 VAL A 309 CYS A 316 -1 N VAL A 309 O GLU A 325 SHEET 1 D 2 ASN A 369 LEU A 374 0 SHEET 2 D 2 ARG A 380 THR A 385 -1 O THR A 385 N ASN A 369 SHEET 1 E 4 VAL A 405 ASN A 406 0 SHEET 2 E 4 LEU A 443 MET A 447 1 O ASN A 444 N ASN A 406 SHEET 3 E 4 SER A 450 VAL A 454 -1 O TYR A 452 N PHE A 445 SHEET 4 E 4 TYR A 561 HIS A 562 1 O HIS A 562 N VAL A 451
SITE 1 AC1 4 ARG A 505 VAL A 530 LYS A 531 THR A 532 SITE 1 AC2 4 ARG A 48 THR A 221 CYS A 223 HOH A 868 SITE 1 AC3 4 TRP A 6 ALA A 9 SER A 46 ALA A 49 SITE 1 AC4 6 PHE A 145 ARG A 386 THR A 390 HOH A 871 SITE 2 AC4 6 HOH A 872 HOH A 945
CRYST1 64.396 214.417 123.192 90.00 90.00 90.00 C 2 2 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015529 0.000000 0.000000 0.00000
SCALE2 0.000000 0.004664 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008117 0.00000